Nxera Pharma Co., Ltd. (TYO:4565)

Nxera Pharma Revenue

Nxera Pharma had revenue of 6.64B JPY in the quarter ending March 31, 2025, with 44.09% growth. This brings the company's revenue in the last twelve months to 30.87B, up 87.83% year-over-year. In the year 2024, Nxera Pharma had annual revenue of 28.84B with 125.87% growth.

• Revenue (ttm): 30.87B
• Revenue Growth: +87.83%
• P/S Ratio: 2.43
• Revenue / Employee: 79.76M
• Employees: 374
• Market Cap: 74.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.84B	16.07B	125.87%
Dec 31, 2023	12.77B	-2.80B	-18.00%
Dec 31, 2022	15.57B	-2.14B	-12.10%
Dec 31, 2021	17.71B	8.87B	100.32%
Dec 31, 2020	8.84B	-884.00M	-9.09%